Click here for three graphs on drug development from Paul Kedrosky’s Infectious Greed web site. Notes Kedrosky: “The first one shows the recent uptick in drugs being developed at all stages; the second shows how the number of new drugs in post-clinical stage is abysmal; and…the third shows the flat-line in new molecular entities (NMEs).”
Corporate Research Group’s Weblog
Inside view on the business of healthcare
Subscribe in RSS Reader
